FFA
CPIX icon

Farther Finance Advisors’s Cumberland Pharmaceuticals CPIX Stock Holding History

Farther Finance Advisors’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-345
Closed -$1.08K – 5483
2025
Q3 		$1.08K Buy
+345
New +$1.15K ﹤0.01% 4344

Other funds holding CPIX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Farther Finance Advisors's CPIX Position: Q4 2025 in Review

Farther Finance Advisors sold out of Cumberland Pharmaceuticals (CPIX) in Q4 2025, closing a stake of 345 shares — an estimated $1.08K sold.

Farther Finance Advisors first reported a position in CPIX in Q3 2025 and held it in 1 quarter. The position peaked at $1.08K in Q3 2025. 27 funds tracked by Wall St. Rank hold CPIX as of Q4 2025.

  • Farther Finance Advisors reported no remaining Cumberland Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Farther Finance Advisors sold 345 Cumberland Pharmaceuticals shares in Q4 2025, an estimated $1.08K.
  • Farther Finance Advisors first reported a position in Cumberland Pharmaceuticals in Q3 2025 and held it in 1 quarter.
  • Farther Finance Advisors's Cumberland Pharmaceuticals position peaked at $1.08K in Q3 2025.
  • 27 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q4 2025.

Based on Farther Finance Advisors's 13F filing for Q4 2025, filed 23 Jan 2026.